News Digest / Ticker: AMGN

Ticker: AMGN

07:25am, Monday, Aug 25, 2025

Royalty Pharma (RPRX) Lays Down Up to $950M for Royalty Stake in Amgen's (AMGN) Lumakras

Royalty Pharma (RPRX) buys up to $950M royalty stake in Amgen's (AMGN) KRAS G12C lung‑cancer drug sotorasib (Lumakras), converting future sales into cash - a bet on trials, label expansion and pricing.

03:44am, Monday, Feb 24, 2025

Amgen Invests $200 Million in New Biotech Hub in India: What This Means for Traders and the Future of Pharma Innovation

Amgen (NASDAQ: AMGN) invests $200 million in a new tech center in Hyderabad, India, focusing on AI and data science for drug development. This move enhances its market presence and aligns with U.S.-India trade talks. Traders should monitor its growth potential.

06:56am, Tuesday, Feb 04, 2025

February 4, 2025: Google, Toyota, and More Reveal Earnings – What to Expect

Key companies reporting earnings on February 4, 2025, include Google (GOOGL, GOOG), Toyota (TM), Merck (MRK), Pfizer (PFE), Pepsico (PEP), and AMD (AMD). Investors should watch for insights that could influence market sentiment and stock movements.